📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical potential of pacritinib in the treatment of myelofibrosis. (2015)

First Author: Duenas-Perez AB

Attributed to: Unravelling biological heterogeneity in neoplastic myeloproliferative stem cells funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1177/2040620715586527

PubMed Identifier: 26288713

Publication URI: http://europepmc.org/abstract/MED/26288713

Type: Journal Article/Review

Volume: 6

Parent Publication: Therapeutic advances in hematology

Issue: 4

ISSN: 2040-6207